CIPHARM
ジェネリック医薬品、錠剤、シロップ、医薬品製剤。
CIPHARM は、アビジャン事業でジェネリック医薬品、錠剤、シロップ、医薬品製剤を製造しています。同社は、上場主要市場全体の薬局チャネル、病院バイヤー、ヘルスケア流通業者、または輸出顧客に製品を供給しています。
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Abidjan, Côte d'Ivoire
- Founded
- 1988
- Website
- cipharm.ci
- Categories
- 医療およびヘルスケア用品, サプリメントとウェルネス
- Markets
- コートジボワール, セネガル, ガーナ, カメルーン
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- debarment-clear (green), checked 2026-08-05 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- sanctions-clear (green), checked 2026-08-05 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- corporate-mail-on-domain (green), checked 2026-08-05 Mail server of the company domain
Claimed certifications, not confirmed by us
- Good Manufacturing Practice
- ISO 9001, Quality Management IAF CertSearch
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)